Ocular myasthenic syndrome, adverse reaction to omalizumab? A case report

Kalteren, Willemien S.; Schreurs, Marco; Jorritsma-Smit, Annelies; Touw, Daan; de Jong, Jan Willem; Zweers, Petra G. M. A.; Reesink, Fransje E.

doi:10.1111/bcp.13338

Kalteren, W.S. (Willemien S.), M.W.J. Schreurs (Marco), Jorritsma-Smit, A. (Annelies), D.J. Touw (Daan), de Jong, J.W. (Jan Willem), Zweers, P.G.M.A. (Petra G. M. A.) and Reesink, F.E. (Fransje E.)

2017

Ocular myasthenic syndrome, adverse reaction to omalizumab? A case report

British Journal of Clinical Pharmacology

Additional Metadata
Keywords	Adverse drug reactions, Neurology, Respiratory medicine
Persistent URL	doi.org/10.1111/bcp.13338, hdl.handle.net/1765/100631
Journal	British Journal of Clinical Pharmacology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Kalteren, W.S. (Willemien S.), Schreurs, M., Jorritsma-Smit, A. (Annelies), Touw, D., de Jong, J.W. (Jan Willem), Zweers, P.G.M.A. (Petra G. M. A.), & Reesink, F.E. (Fransje E.). (2017). Ocular myasthenic syndrome, adverse reaction to omalizumab? A case report. British Journal of Clinical Pharmacology. doi:10.1111/bcp.13338

Ocular myasthenic syndrome, adverse reaction to omalizumab? A case report

Publication

Publication

About

Ocular myasthenic syndrome, adverse reaction to omalizumab? A case report

Publication

Publication

Workflow

Workflow

Add Content